Volcano's Shares Erupt: What You Need to Know

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Motley Fool Rule Breakers recommendation Volcano (Nasdaq: VOLC  ) surged as much as 10% in intraday trading, after exceeding analyst estimates for first-quarter financial results.

So what: Interestingly, the move up came despite lower full-year guidance. Management cited $5 million worth of revenue impact from the twin tsunamis that struck Japan in March in lowering Volcano's 2011 targets from a range of $347 million to $352 million in revenue and $0.22 to $0.24 in per-share earnings to $342 million to $347 million in revenue and $0.19 to $0.21 in per-share profit. The revised estimates remained within reach of the midpoint of Wall Street's own projections.

Now what: Not so for Q1 results, however. Demand for Volcano's cardiac-imaging technology surged as revenue improved by 22% to $80.9 million. Markedly higher gross margin -- up 560 basis points year over year -- transformed last year's $0.08-per-share loss into a $0.02-per-share profit. Analysts had been expecting $78.4 million and a $0.03-per-share loss. Even though Volcano trades for a significant premium to peers Boston Scientific (NYSE: BSX  ) and St. Jude Medical (NYSE: STJ  ) , judging by these results, it's worth every penny.

Interested in more info on Volcano? Add it to your watchlist.

Fool contributor Tim Beyers is a member of the Motley Fool Rule Breakers stock-picking team. Volcano is a Rule Breakers recommendation. You can try any of our Foolish newsletter services free for 30 days.

Tim didn't own shares in any of the companies mentioned in this article at the time of publication. Check out his portfolio holdings and Foolish writings, or connect with him on Twitter as @milehighfool. You can also get his insights delivered directly to your RSS reader. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool is also on Twitter as @TheMotleyFool. Its disclosure policy is at least 10% better than other disclosure policies.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1489596, ~/Articles/ArticleHandler.aspx, 10/28/2016 6:49:28 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 9 hours ago Sponsored by:
DOW 18,169.68 -29.65 -0.16%
S&P 500 2,133.04 -6.39 -0.30%
NASD 5,215.97 -34.29 -0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 4:01 PM
BSX $21.49 Down -0.60 -2.72%
Boston Scientific CAPS Rating: ***
STJ $79.01 Up +0.31 +0.39%
St. Jude Medical CAPS Rating: **
VOLC.DL $0.00 Down +0.00 +0.00%
Volcano CAPS Rating: **